Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katsuto Tamai

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 17, 2012
[Stem cell therapy for intractable skin diseases]Katsuto Tamai
The Journal of Investigative Dermatology|October 25, 2016
Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?Katsuto Tamai, Jouni Uitto
The Journal of Gene Medicine|December 7, 2006
Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vectorSaroj Suvanasuthi, Katsuto Tamai, Yasufumi Kaneda
Trends in Molecular Medicine|July 8, 2009
Molecular therapies for heritable blistering diseasesKatsuto Tamai, Yasufumi Kaneda, Jouni Uitto
Journal of Dermatological Science|September 4, 2007
Cutaneous gene deliveryYasushi Kikuchi, Katsuto Tamai, Yasufumi Kaneda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ productionKotaro Saga, Katsuto Tamai, Takehiko Yamazaki, et al.
Cellular and Molecular Life Sciences : CMLS|December 25, 2024
Guided monocyte fate to FRβ/CD163<sup>+</sup> S1 macrophage antagonises atopic dermatitis via fibroblastic matrices in mouse hypodermisYu-Tung Li, Eiichi Takaki, Yuya Ouchi, et al.
Case Reports in Dermatology|October 17, 2019
A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin DimpleMadoka Takafuji, Atsushi Tanemura, Yuma Hanaoka, et al.
Stem Cells and Development|August 20, 2016
Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model MiceEriko Aikawa, Ryo Fujita, Maiko Asai, et al.
Scientific Reports|June 6, 2015
Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrowEriko Aikawa, Ryo Fujita, Yasushi Kikuchi, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 17, 2012
[Stem cell therapy for intractable skin diseases]Katsuto Tamai
The Journal of Investigative Dermatology|October 25, 2016
Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?Katsuto Tamai, Jouni Uitto
The Journal of Gene Medicine|December 7, 2006
Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vectorSaroj Suvanasuthi, Katsuto Tamai, Yasufumi Kaneda
Trends in Molecular Medicine|July 8, 2009
Molecular therapies for heritable blistering diseasesKatsuto Tamai, Yasufumi Kaneda, Jouni Uitto
Journal of Dermatological Science|September 4, 2007
Cutaneous gene deliveryYasushi Kikuchi, Katsuto Tamai, Yasufumi Kaneda
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ productionKotaro Saga, Katsuto Tamai, Takehiko Yamazaki, et al.
Cellular and Molecular Life Sciences : CMLS|December 25, 2024
Guided monocyte fate to FRβ/CD163<sup>+</sup> S1 macrophage antagonises atopic dermatitis via fibroblastic matrices in mouse hypodermisYu-Tung Li, Eiichi Takaki, Yuya Ouchi, et al.
Case Reports in Dermatology|October 17, 2019
A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin DimpleMadoka Takafuji, Atsushi Tanemura, Yuma Hanaoka, et al.
Stem Cells and Development|August 20, 2016
Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model MiceEriko Aikawa, Ryo Fujita, Maiko Asai, et al.
Scientific Reports|June 6, 2015
Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα(+) mesenchymal cells from bone marrowEriko Aikawa, Ryo Fujita, Yasushi Kikuchi, et al.
Pageof 10